WO2007085681A1 - Substance thérapeutique contenant des sels de magnésium pour le traitement de tumeurs ou similaires, et utilisation de sels de magnésium - Google Patents

Substance thérapeutique contenant des sels de magnésium pour le traitement de tumeurs ou similaires, et utilisation de sels de magnésium Download PDF

Info

Publication number
WO2007085681A1
WO2007085681A1 PCT/FI2006/000394 FI2006000394W WO2007085681A1 WO 2007085681 A1 WO2007085681 A1 WO 2007085681A1 FI 2006000394 W FI2006000394 W FI 2006000394W WO 2007085681 A1 WO2007085681 A1 WO 2007085681A1
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
treatment substance
magnesium sulfate
warts
magnesium salts
Prior art date
Application number
PCT/FI2006/000394
Other languages
English (en)
Inventor
Kari Honkanen
Original Assignee
Medgenerics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medgenerics Oy filed Critical Medgenerics Oy
Priority to EP06820070A priority Critical patent/EP1976540A4/fr
Publication of WO2007085681A1 publication Critical patent/WO2007085681A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne d'une part une substance thérapeutique contenant des sels de magnésium pour le traitement de tumeurs ou similaires et, d'autre part, une nouvelle utilisation du sulfate de magnésium. La substance thérapeutique, utilisée notamment pour éliminer par voie interne des verrues, est essentiellement à base de sulfate de magnésium en tant que principe actif, la substance thérapeutique étant formulée pour l'administration par voie rectale, par exemple sous la forme d'un suppositoire ou similaire.
PCT/FI2006/000394 2006-01-24 2006-11-29 Substance thérapeutique contenant des sels de magnésium pour le traitement de tumeurs ou similaires, et utilisation de sels de magnésium WO2007085681A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06820070A EP1976540A4 (fr) 2006-01-24 2006-11-29 Substance thérapeutique contenant des sels de magnésium pour le traitement de tumeurs ou similaires, et utilisation de sels de magnésium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20060065A FI119101B (fi) 2006-01-24 2006-01-24 Magnesiumsuoloja sisältävä hoitoaine kasvainten tai vastaavien hoitoon ja magnesiumsulfaatin käyttö
FI20060065 2006-01-24

Publications (1)

Publication Number Publication Date
WO2007085681A1 true WO2007085681A1 (fr) 2007-08-02

Family

ID=35883876

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FI2006/000394 WO2007085681A1 (fr) 2006-01-24 2006-11-29 Substance thérapeutique contenant des sels de magnésium pour le traitement de tumeurs ou similaires, et utilisation de sels de magnésium

Country Status (3)

Country Link
EP (1) EP1976540A4 (fr)
FI (1) FI119101B (fr)
WO (1) WO2007085681A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009798A1 (fr) * 1992-10-29 1994-05-11 C-P Technology Limited Partnership Melanges ou complexes contenant du calcium et du sulfate
WO1999038517A1 (fr) * 1998-01-30 1999-08-05 Bene Pharma Oy Compositions de traitement de verrues par voie orale
US6218192B1 (en) * 1991-04-08 2001-04-17 Research Foundation Of The State University Of New York Method and composition for treatment of headache using magnesium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499984A (en) * 1975-04-16 1978-02-01 Unigate Foods Ltd Dietary foods
IT1272994B (it) * 1994-05-25 1997-07-01 Giampiero Valletta Uso di prodotti contenenti magnesio nella terapia e nella profilassi di malattie neoplastiche e di malattie di tipo autoimmunitario.-

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218192B1 (en) * 1991-04-08 2001-04-17 Research Foundation Of The State University Of New York Method and composition for treatment of headache using magnesium
WO1994009798A1 (fr) * 1992-10-29 1994-05-11 C-P Technology Limited Partnership Melanges ou complexes contenant du calcium et du sulfate
WO1999038517A1 (fr) * 1998-01-30 1999-08-05 Bene Pharma Oy Compositions de traitement de verrues par voie orale

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1976540A4 *

Also Published As

Publication number Publication date
FI119101B (fi) 2008-07-31
EP1976540A4 (fr) 2010-07-28
FI20060065A0 (fi) 2006-01-24
EP1976540A1 (fr) 2008-10-08
FI20060065A (fi) 2007-07-25

Similar Documents

Publication Publication Date Title
US5589480A (en) Topical application of opioid analgesic drugs such as morphine
EA032439B1 (ru) Композиции и способы для лечения поверхностных ран
CN108853312A (zh) 聚桂醇外用凝胶及其制备方法
DK166479B (da) Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning
RU2006139819A (ru) Применение симетикона для предрасположенных к запорам пациентов
US5278172A (en) Method and composition for treating tendon or joint inflammation using a vasodilator
CN102188572B (zh) 一种治疗骨伤的中药
CN103977194A (zh) 能有效治疗创面感染的外用药在制备治疗糖尿病足药物中的应用
US5576329A (en) Method for treating tendon or joint inflammation with papaverine HCL
EP2322177B1 (fr) Utilisation d'une préparation contenant de la nifédipine pour traiter le vaginisme
JPH08500343A (ja) セシウムイオンを用いた治療方法
EP1976540A1 (fr) Substance thérapeutique contenant des sels de magnésium pour le traitement de tumeurs ou similaires, et utilisation de sels de magnésium
CN1669562A (zh) 筋骨康复膏及其制备方法
CN103585257B (zh) 一种治疗骨折的中药散剂
CN102078516B (zh) 一种治疗骨伤的中药
CN102512650A (zh) 一种治疗面神经麻痹的外用药物
CN104056080A (zh) 一种治疗脑血栓后遗症的中药组合物
RU2357747C1 (ru) Способ лечения больных псориатической болезнью
RU2181995C1 (ru) Способ лечения миофасциального болевого синдрома
CN107569577A (zh) 一种药物组合物在制备治疗三叉神经痛的药物中的应用
RU2286791C1 (ru) Способ лечения рубцов
CN103110748B (zh) 一种治疗性病的复方中药组合物及其用途
RU2200557C1 (ru) Способ лечения гипертрофических и келоидных рубцов
RU2182006C2 (ru) Способ лечения ревматоидного артрита
Efraimidis et al. Efficacy of laser application for the rehabilitation of patients with Bell's palsy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006820070

Country of ref document: EP